SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C57 - Neurology Update II: Movement, Spine, and Autonomic Neurology

Event Time: Sunday April 23, 2017 3:30 pm to 5:30 pm
Topic(s): General Neurology, General Neurology: Overview
Director(s): Joseph Safdieh MD, FAAN
Description: One of the primary goals of the AAN is to help its members stay up-to-date on the latest developments in the diagnosis and management of neurologic disorders. This course will provide updates on movement disorders, spine disorders, and autonomic neurology. This program complements C40: Neurology Update I: Epilepsy, Headache, and Neurologic Infections, C122: Neurology Update III: Neuromuscular, Dementia, and Stroke, and C137: Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies. The topics in the Neurology Update programs do not overlap and the four Update programs can provide a comprehensive update of all major fields in neurology.
Completion Message: Participants should have knowledge of the most current recommendations for the diagnosis, management, and therapy of patients with the disorders discussed, and be able to put recent developments in context to provide optimal patient care.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care, Practice-Based Learning and Improvement

Program Speakers - Tentative

Start/End Time Title Faculty
3:30 PM - 4:00 PM Update in Movement Disorders Claire Henchcliffe MD, PhD, FAAN 
4:00 PM - 4:30 PM Update in Spine Disorders J. D. Bartleson MD, FAAN 
4:30 PM - 5:00 PM Update in Autonomic Neurology Roy Freeman MD 
5:00 PM - 5:30 PM Questions and Answers Faculty 

Disclosures

Speaker Disclosure
J. D. Bartleson, MD, FAAN Dr. Bartleson has nothing to disclose.

Roy L. Freeman, MD Dr. Freeman has received personal compensation for activities with Abide, Astellas, Biogen, Daiichi-Sankyo, Grunental, Lundbeck, Nestkem Novartis, Pfizer as a member of a scientific advisory board. Dr. Freeman has received personal compensation in an editorial capacity for Autonomic Neuroscience. Dr. Freeman has received research support from Pfizer and Astra-Zeneca.

Claire Henchcliffe, MD, PhD, FAAN Dr. Henchcliffe has received personal compensation for activities with Acadia, Impax and Teva Pharmaceuticals as a speaker. Dr. Henchcliffe has received personal compensation from Acadia and US WorldMeds as an advisory board member.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C2 Functional Neurologic Disorders I: Movement, Seizures, and Speech Disorders Alberto Espay MD, FAAN
7:00 AM-4:00 PM
C6 Neurology MOC Prep Course Nicholas Johnson MD
9:30 AM-11:30 AM
C8 Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C12 Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
12:00 PM-1:00 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
1:30 PM-3:30 PM
C22 Critical Care Consultations for Neurohospitalists Vanja Douglas MD
4:15 PM-5:30 PM
PL1 Hot Topics Plenary Session

Wednesday April 25, 2018

7:00 AM-9:00 AM
C138 Neurologic Case Studies in Pregnancy Mary O'Neal MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C143 Neurology Update I: Epilepsy, Behavioral Neurology, and Neurologic Infections Ralph Jozefowicz MD, FAAN
C147 LGBTQI Health in Neurology Holly Hinson MD, MCR
3:30 PM-5:30 PM
C159 Neurology Update II: Movement Disorders, Spine Disorders, and Sleep Disorders Ralph Jozefowicz MD, FAAN
C167 CNS Toxicities Neeraj Kumar MD

MEMBER LOG IN

Forgot Password?